Vivimed Labs share news, announcements and annual reports
NSE: VIVIMEDLABBSE: 532660Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 30 Oct 2026. Previous close ₹5.64.
30 Oct: open ₹5.62, high ₹5.64, low ₹5.53
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹46 Cr3,293rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,267
Vivimed Labs share news and announcements
642 announcements, routine notices left out, newest first. Page 3 of 13.
Apr 2024
3 Apr · Updates
Feb 2024
14 Feb · Results
Jan 2024
31 Jan · Board meeting
Nov 2023
14 Nov · Results
14 Nov · Meeting
Oct 2023
28 Oct · Board meeting
20 Oct · Meeting
18 Oct · Board meeting
Sep 2023
11 Sep · Meeting
Aug 2023
14 Aug · Results
14 Aug · Board meeting
Jul 2023
28 Jul · Board meeting
Jun 2023
16 Jun · Legal
Exchange has sought clarification from Vivimed Labs Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.14 Jun · Updates
May 2023
30 May · Results
18 May · Board meeting
Apr 2023
3 Apr · Updates
Mar 2023
27 Mar · Meeting
17 Mar · Address Change
3 Mar · Updates
Feb 2023
15 Feb · Meeting
13 Feb · Results
1 Feb · Board meeting
Jan 2023
13 Jan · Board meeting
10 Jan · Board meeting
10 Jan · Updates
Nov 2022
22 Nov · Related Party Transaction
Oct 2022
Aug 2022